Filter
29
Featured
Recommendations
4
New Publications
6
Language
Document type
Guidelines
12
Studies & Reports
8
Training Material
3
Fact sheets
2
No document type
2
Infographics
1
Strategic & Response Plan
1
Countries / Regions
South Africa
3
Uganda
2
Malawi
2
Namibia
1
Ukraine
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
5
Studies & Reports
4
Statistics
1
Toolboxes
ART Drug Resistance, treatment failure
16
Drug resistance
4
Antiretroviral Therapies (ART)
3
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
3
Differentiated Service Delivery
2
Treatment Guidelines HIV
2
Behaviour Change/Life Skill Education
2
Adherence
2
HIV Testing Modalities, incl. VCT
1
Clinical Guidelines
1
HIV in Key Populations
1
Testing Guidelines
1
Clinical aspects
1
Eastern and Southern Africa
1
Discrimination & Stigma
1
African Region
1
Standard Operating Procedures (SOPs)
1
Retention
1
Treatment Interruption-engagement
1
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable
...
En la presente publicación se formulan orientaciones sobre la respuesta de salud pública a la farmacorresistencia del VIH (FRVIH) a inhibidores no nucleosídicos de la retrotranscriptasa (INNRT), previa al tratamiento, en personas con exposición previa a los fármacos antirretrovirales (ARV) o si
...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a ...
WHO recommends that a ...
